Financials

Discussions Technicals Seasonals

048530 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

iNtRON Biotechnology, Inc. engages in the development of new biopharmaceuticals, alternatives to antibiotics for animals, and molecular diagnosis. It operates through the New Testament Part and DR Part business divisions. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

048530 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company